4Uloth RH, Kirk, JR, Gould WA et al.[J]. Med chem., 1966,9(1):88.
5Nemec J, Shen W K. Antiarrhythmic drugs:new agents and evolving concepts[J]. Expert Opin Investig Drug, 2003,12(3):435-453.
6Viswanathan P C, Rudy Y. Cellular arrhythmogenic effects of congenital and acquired long-QT syndrome in the heterogeneous myocardium [J]. Circulation, 2000, 101(1):1192-1998.
7Glatter K A, Dorostkar P C, Yang Y, et al. Electrophysiological effects of ibutilide in patients with accessory pathways[J]. Circulation, 2001,104:1933-1939.
8Gerlach U. ⅠKs channel blockers:potential antiarrhythmic agents[J]. Drugs Fut,2001,26(5):473-484.
9Church J, Mclarnon J G. Tedisamil blocks BK-type Ca(2+)-dependent K+ Channels and modulates action potentlals in rat hippocampal neurons[J]. Neurosci Lett,2002,319:79-82.
10Kovoor P, Wickman K, Maguire C T,et al. Evaluation of the role of I(KACH) in atrial fibrillation using a mouse knockout model[J]. J Am Coll Cardiol,2001,37:2136-2143.
